Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer

PURPOSE: Amplification of MYC is one of the most common genetic alterations in lung cancer, contributing to a myriad of phenotypes associated with growth, invasion and drug resistance. Murine genetics has established both the centrality of somatic alterations of Kras in lung cancer, as well as the d...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Shimamura, Takeshi, Chen, Zhao, Soucheray, Margaret, Carretero, Julian, Kikuchi, Eiki, Tchaicha, Jeremy H., Gao, Yandi, Cheng, Katherine A., Cohoon, Travis J., Qi, Jun, Akbay, Esra, Kimmelman, Alec C., Kung, Andrew L., Bradner, James E., Wong, Kwok-Kin
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3838895/
https://ncbi.nlm.nih.gov/pubmed/24045185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3904
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים